CN Stock MarketDetailed Quotes

688319 Chengdu Olymvax Biopharmaceuticals Inc

Watchlist
  • 14.16
  • +0.20+1.43%
Trading Mar 24 13:51 CST
5.75BMarket Cap-674.29P/E (TTM)

Chengdu Olymvax Biopharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chengdu Olymvax Biopharmaceuticals Inc FY2024 Estimates Date

Currency：CNYMar 29, 2025

Estimate YoY
Revenue
557.00M
+12.27%
EPS
0.07
+63.17%
Analyst Rating
Strong Buy

Mar 24, 2025

Chengdu Olymvax Biopharmaceuticals Inc Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 703.000M--
--2025/FY-- / 631.000M--
Mar 29, 20252024/FY588.858M / 557.000M--
--2023/FY496.119M / 632.763M--
--2022/FY547.481M / 595.000M--
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 703.000M--
--2025/FY-- / 631.000M--
Mar 29, 20252024/FY588.858M / 557.000M--
--2023/FY496.119M / 632.763M--
--2022/FY547.481M / 595.000M--

Unlock Free Earnings Estimates

Chengdu Olymvax Biopharmaceuticals Inc Earnings Reports

  • Olin Biotech: Chengdu Olin Biotechnology Co., Ltd. 2024 Annual Results Express Announcement

    Feb 27 11:00 ET

  • Chengdu Olin Biotechnology Co., Ltd. 2024 Annual Results Express Announcement

    Feb 27 11:00 ET

  • Chengdu Olin Biotechnology Co., Ltd. Report for the Third Quarter of 2024

    Oct 29, 2024 12:00 ET

  • Chengdu Olin Biotechnology Co., Ltd. 2024 Interim Report

    Aug 21, 2024 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    Sidea Semiconductor Equipment
    301629
    168.57 +222.44%
    Jiangyin Electrical Alloy
    300697
    17.34 +20.00%
    Nanjing Wondux Environmental Protection Technology Corp., Ltd.
    688178
    20.48 +19.98%
    Zhang Xiaoquan Inc.
    301055
    19.04 +19.97%
    Dook Media
    301025
    10.94 +19.96%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Mar 24, 2025

    Strong Buy

    • Strong Buy

      80.00%

    • Buy

      20.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Finance and Securities Lending
    Finance and Securities Lending
    Intraday-0.72%
    Transferring Securities of Securities
    Transferring Securities of Securities
    Intraday-0.72%
    Biological Vaccine
    Biological Vaccine
    Intraday-1.10%